Suppr超能文献

人间充质基质细胞介导的免疫调节:作用机制与临床应用

Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications.

作者信息

Dorronsoro Akaitz, Fernández-Rueda Jon, Fechter Karoline, Ferrin Izaskun, Salcedo Juan Manuel, Jakobsson Emma, Trigueros César

机构信息

Mesenchymal and Hematopoietic Stem Cell Department, Fundación Inbiomed, Foundation for Stem Cell Research, Paseo Mikeletegi 81, 20009 San Sebastián, Spain.

出版信息

Bone Marrow Res. 2013;2013:203643. doi: 10.1155/2013/203643. Epub 2013 Sep 29.

Abstract

Mesenchymal stromal cells (MSCs) are multipotent cells found in connective tissues that can differentiate into bone, cartilage, and adipose tissue. Interestingly, they can regulate immune responses in a paracrine way and allogeneic MSCs do not elicit immune response. These properties have encouraged a number of clinical trials in a broad range of regenerative therapies. Although these trials were first focused on their differentiation properties, in the last years, the immunosuppressive features have gained most of the attention. In this review, we will summarize the up-to-date knowledge about the immunosuppressive mechanisms of MSCs in vivo and in vitro and the most promising approaches in clinical investigation.

摘要

间充质基质细胞(MSCs)是存在于结缔组织中的多能细胞,可分化为骨、软骨和脂肪组织。有趣的是,它们能够以旁分泌方式调节免疫反应,而异基因MSCs不会引发免疫反应。这些特性促使人们在广泛的再生疗法中开展了多项临床试验。尽管这些试验最初关注的是其分化特性,但在过去几年中,免疫抑制特性受到了最多关注。在这篇综述中,我们将总结关于MSCs体内和体外免疫抑制机制的最新知识以及临床研究中最有前景的方法。

相似文献

1
Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications.
Bone Marrow Res. 2013;2013:203643. doi: 10.1155/2013/203643. Epub 2013 Sep 29.
2
Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine.
Anat Rec (Hoboken). 2014 Jan;297(1):98-110. doi: 10.1002/ar.22798. Epub 2013 Dec 2.
4
Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Past, Present, and Future.
Cell Reprogram. 2017 Aug;19(4):217-224. doi: 10.1089/cell.2016.0062. Epub 2017 May 18.
5
Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials.
Stem Cells Int. 2010 Oct 31;2010:503593. doi: 10.4061/2010/503593.
6
Clinical Trials With Mesenchymal Stem Cells: An Update.
Cell Transplant. 2016;25(5):829-48. doi: 10.3727/096368915X689622. Epub 2015 Sep 29.
7
Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.
Stem Cell Res Ther. 2020 Aug 8;11(1):345. doi: 10.1186/s13287-020-01855-9.
8
Potential therapeutic applications of mesenchymal stromal cells.
Pathology. 2011 Oct;43(6):592-604. doi: 10.1097/PAT.0b013e32834ab72d.
9
Immunosuppressive properties of mesenchymal stem cells: advances and applications.
Curr Mol Med. 2012 Jun;12(5):574-91. doi: 10.2174/156652412800619950.
10
Multipotent mesenchymal stromal cells: clinical applications and cancer modeling.
Adv Exp Med Biol. 2012;741:187-205. doi: 10.1007/978-1-4614-2098-9_13.

引用本文的文献

2
Adipose tissue-derived mesenchymal stem cells reduce endometriosis cellular proliferation through their anti-inflammatory effects.
Clin Exp Reprod Med. 2021 Dec;48(4):322-336. doi: 10.5653/cerm.2021.04357. Epub 2021 Dec 1.
4
Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases.
Int J Mol Sci. 2021 May 22;22(11):5487. doi: 10.3390/ijms22115487.
6
Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation.
Sci Rep. 2020 Dec 14;10(1):21853. doi: 10.1038/s41598-020-78864-4.
7
Mesenchymal Stromal Cells' Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
Front Cell Neurosci. 2020 Oct 6;14:584277. doi: 10.3389/fncel.2020.584277. eCollection 2020.
9
Mesenchymal Stromal Cells Support Endometriotic Stromal Cells .
Stem Cells Int. 2018 Jan 28;2018:7318513. doi: 10.1155/2018/7318513. eCollection 2018.

本文引用的文献

3
The immunosuppressive molecule HLA-G and its clinical implications.
Crit Rev Clin Lab Sci. 2012 May-Jun;49(3):63-84. doi: 10.3109/10408363.2012.677947. Epub 2012 Apr 26.
4
IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB.
Stem Cell Rev Rep. 2012 Sep;8(3):905-16. doi: 10.1007/s12015-012-9364-9.
8
Mesenchymal stromal cell 'licensing': a multistep process.
Leukemia. 2011 Sep;25(9):1408-14. doi: 10.1038/leu.2011.108. Epub 2011 May 27.
10
Mesenchymal stromal cells: more than inhibitory cells.
Leukemia. 2011 Apr;25(4):565-6. doi: 10.1038/leu.2011.8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验